Pathologic Complete Response After Neoadjuvant Chemoradiation in a Patient with Gastric Neuroendocrine Cancer

Neuroendocrine tumors are about 0.5% of all malignancies. Specifically, for gastrointestinal (GI) malignancies, neuroendocrine tumor incidence is approximately 1%-2% per year. Gastric neuroendocrine neoplasms are rare and consist of various tumor types with differing histomorphology, pathogenesis, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Laughlin, Brady, Scott, Aaron, Goyal, Uma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758975/
https://www.ncbi.nlm.nih.gov/pubmed/31565618
http://dx.doi.org/10.7759/cureus.5214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758975/
https://www.ncbi.nlm.nih.gov/pubmed/31565618
http://dx.doi.org/10.7759/cureus.5214

Ejemplares similares